Cargando…

P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy

Detalles Bibliográficos
Autores principales:	Weiler, K, Rava, L, Jäger, M, Funke, I, Joka, M, Jauch, KW, Mayer, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072014/ http://dx.doi.org/10.1186/2051-1426-2-S2-P9

Ejemplares similares

Review of catumaxomab in the treatment of malignant ascites
por: Sebastian, Martin
Publicado: (2010)

Palliative treatment of malignant ascites: profile of catumaxomab
por: Ammouri, Lila, et al.
Publicado: (2010)

Prothrombin complex concentrate use in surgical patients: a retrospective analysis of efficacy and safety for coumarin reversal and bleeding management
por: Schick, KS, et al.
Publicado: (2008)

Platelet/leukocyte ratio as a predictor of mortality in patients with sepsis
por: Menezes, Bárbara Magalhães, et al.
Publicado: (2013)

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients
por: Ruf, Peter, et al.
Publicado: (2010)

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes
por: Galetta, Henry, et al.
Publicado: (2015)

Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab(®))
por: Seimetz, Diane
Publicado: (2011)

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
por: Janssen, Nicole, et al.
Publicado: (2015)

Rapid shallow breathing index – a key predictor for noninvasive ventilation
por: Crawford, J, et al.
Publicado: (2007)

Leukocyte immunophenotyping: methodological aspects
por: Jämsä, J, et al.
Publicado: (2010)

Apheresis of activated leukocytes with an immobilized polymyxin B filter
por: Takeyama, N, et al.
Publicado: (2010)

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report
por: Bezan, Angelika, et al.
Publicado: (2013)

Toll-like receptor ligands regulate the migratory pattern of leukocytes
por: Nieto, J C, et al.
Publicado: (2010)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

Protein Kinase G is a key regulator of murine white adipogenesis
por: Mitschke, Michaela M, et al.
Publicado: (2011)

Chemotherapy-induced modulation of [(18)F]Fluoro-2-deoxy-D-glucose incorporation at the tumour cell level
por: Sharma, RI, et al.
Publicado: (2008)

Increased leukocyte transit times through capillaries contributes to maldistribution of flow
por: Jeganathan, T, et al.
Publicado: (2005)

Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro
por: Seeber, Andreas, et al.
Publicado: (2015)

P01.18. Triterpene acid containing Viscum album L. extracts mediate apoptosis in paediatric solid cancer cells
por: Kauczor, G, et al.
Publicado: (2012)

Time of course CD64, a leukocyte activation marker, during extracorporeal circulation
por: Djebara, S, et al.
Publicado: (2012)

Immunoregulatory role of secretory leukocyte protease inhibitor in allergic asthma
por: Marino, Rafael, et al.
Publicado: (2010)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Propofol and methohexital comparably affect polymorphonuclear leukocyte function in patients after cardiac surgery
por: Hüttemann, E, et al.
Publicado: (2005)

Increased leukocyte oxidative metabolism in severe sepsis and septic shock correlates with organ dysfunction and mortality
por: Martins, P, et al.
Publicado: (2006)

In vivo leukocyte–endothelium interactions in rat mesenteric microvessels after ischemia/reperfusion and sepsis
por: Nakagawa, NK, et al.
Publicado: (2005)

Lipopolysaccharide is required for leukocyte adhesion to Toraymyxin(® )filters used in the treatment of sepsis
por: Martin, EL, et al.
Publicado: (2010)

Does leukocyte apoptosis play any role in the pathogenesis of experimental pancreatitis?
por: Zotos, D, et al.
Publicado: (2011)

Poster 1008: Dialyzable leukocyte extracts as adjuvant treatment for allergic rhinitis
por: Homberg, Toni Angela, et al.
Publicado: (2014)

Changes in levels of BNP, CRP and leukocyte formula during exercise testing in patients with dilated cardiomyopathy
por: Peric, V, et al.
Publicado: (2013)

Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
por: Goéré, Diane, et al.
Publicado: (2014)

Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer
por: Ziai, James, et al.
Publicado: (2015)

Alpha-1-acid glycoprotein reduces hepatic leukocyte recruitment in early sepsis
por: Fox-Robichaud, A, et al.
Publicado: (2005)

Role of the leukocyte antisedimentation rate in prediction of early recognition of post-stroke infection
por: Molnar, T, et al.
Publicado: (2008)

Characterization of multiple myeloma osseous lesions and diffuse infiltration pattern by 18F-FDG-PET/CT, static MRI and diffusion-weighted MR Imaging (DWI-MRI): a comparative multimodality imaging study
por: Mosebach, J, et al.
Publicado: (2014)

Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant
por: Fernandez-Ortega, C, et al.
Publicado: (2010)

Microcirculatory, leukocyte/endothelium interaction and survival time effects of recombinant C-reactive protein in nonhypotensive endotoxemia in hamsters
por: Silva, M, et al.
Publicado: (2009)

The TLR4 antagonist CRX-526 reduces LPS-induced leukocyte activation and improves capillary perfusion of the rat intestine
por: Soltow, M, et al.
Publicado: (2010)

Characterization of tumor infiltrated cells in mouse model
por: Liou, Yae-Huei, et al.
Publicado: (2015)

Leukocyte infiltration patterns and structural changes in severe asthmatics with variable degree of clinical control
por: Anders, Bergqvist, et al.
Publicado: (2015)

Soluble 4A11 antigen: a novel mediator of leukocyte-endothelial adhesion and monocyte recruitment in rheumatoid arthritis
por: Koch, A, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_6etlb40vggva3p5bil0531nesb